Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.
Diabetes Ther
; 13(3): 551-567, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35230650
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
Language:
En
Year:
2022
Type:
Article